Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
Felix Fiehn, Claudia Beisel, Marco Binder
Abstract
Chronic hepatitis C virus (HCV) infection is a major cause of hepatic fibrosis and cirrhosis, with a risk for the development of hepatocellular carcinoma (HCC). Although highly effective direct-acting antivirals (DAAs) are available, the incidence, morbidity, and mortality of HCV-associated HCC are still high. This article reviews the current knowledge of the mechanisms of HCV-induced carcinogenesis with a special focus on those processes that continue after virus clearance and outlines implications for patient surveillance after DAA treatment.
Topics & Concepts
Hepatocellular carcinomaHepatitis C virusCirrhosisCarcinogenesisVirusHepatitis CHepacivirusIncidence (geometry)VirologyBiologyMedicineInternal medicineCancerOpticsPhysicsHepatitis C virus researchLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation